HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicholas D Osteraas Selected Research

2,2,6,6- tetramethylpiperidine- N- oxide- 4- amino- 4- carboxylic acid (TOAC)

10/2021Timing of Anticoagulation after Stroke in Patients with Non-Valvular Atrial Fibrillation Assessment of Provider Practices.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicholas D Osteraas Research Topics

Disease

3Stroke (Strokes)
04/2022 - 01/2020
3Ischemic Stroke
10/2021 - 11/2019
2COVID-19
07/2020 - 01/2020
1Transient Ischemic Attack
04/2022
1Hemorrhagic Stroke
10/2021
1Atrial Fibrillation
10/2021
1Intracranial Hemorrhages (Intracranial Hemorrhage)
09/2020
1Embolic Stroke
11/2019

Drug/Important Bio-Agent (IBA)

2Tissue Plasminogen Activator (Alteplase)FDA Link
04/2022 - 01/2020
12,2,6,6- tetramethylpiperidine- N- oxide- 4- amino- 4- carboxylic acid (TOAC)IBA
10/2021
1Eptifibatide (Integrilin)FDA Link
09/2020

Therapy/Procedure

1Therapeutics
04/2022
1Critical Care (Surgical Intensive Care)
07/2020
1Septal Occluder Device
11/2019